| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Folic acid[1] | B-vitamin | 400–500 µg PO daily preconception through 12 weeks; 5 mg/day in high-risk groups (prior NTD, diabetes, ASM, BMI ≥30, sickle cell, thalassaemia) | — | Reduces neural tube defect; widely available combined with iron in Indian government supply |
| Iron + folic acid[1] | Iron-folate combination | 100 mg elemental iron + 500 µg folic acid PO daily for at least 100 days from second half of pregnancy (Indian public health programme); higher dose for established anaemia | — | Universal supplementation in high-prevalence anaemia settings; switch to therapeutic dose for established IDA; intravenous iron if oral inadequate |
| Calcium supplementation[1] | Mineral supplement | 1.5–2 g elemental calcium PO daily from 20 weeks where dietary intake <600 mg/day | — | Reduces pre-eclampsia and severe outcomes; take separately from iron supplement to avoid absorption interference |
| Aspirin (for pre-eclampsia prevention)[1] | Antiplatelet (low-dose) | 150 mg PO at night from 12+0 to 36+0 weeks for women at high risk for pre-eclampsia | — | Prior PE, chronic HTN, T1/T2DM, autoimmune disease, twins, age ≥40, BMI ≥35, family history; combine with calcium where dietary intake low |
Schedule of antenatal visits, screening, supplementation, and risk-stratification across the three trimesters of pregnancy.